Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brugada syndrome.

Johnson Francis1, Charles Antzelevitch

  • 1Medical College Calicut, Kerala, India. pulikkottil2002@hotmail.com

International Journal of Cardiology
|May 11, 2005
PubMed
Summary
This summary is machine-generated.

Brugada syndrome, a genetic heart condition, can cause sudden death. While SCN5A mutations are implicated, new gene loci and testosterone

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biophysical Characterization of a Novel KCNJ8 Rare Variant Linked With Inherited and Acquired J Wave Syndrome.

JACC. Clinical electrophysiology·2026
Same author

Exploring sex-specific clinical features in Chinese patients with Takotsubo syndrome.

BMC cardiovascular disorders·2025
Same author

Characterization of novel arrhythmogenic patterns arising secondary to heterogeneous expression and activation of Nav1.8.

Frontiers in cardiovascular medicine·2025
Same author

The Efficacy of I Na Block to Cardiovert Atrial Fibrillation Is Enhanced by Inhibition of I K1.

Journal of cardiovascular pharmacology·2024
Same author

The potential anti-arrhythmic effect of SGLT2 inhibitors.

Cardiovascular diabetology·2024
Same author

Gene and stem cell therapy for inherited cardiac arrhythmias.

Pharmacology & therapeutics·2024

Area of Science:

  • Cardiology
  • Genetics
  • Electrophysiology

Background:

  • Brugada syndrome is an autosomal dominant disorder causing syncope and sudden cardiac death.
  • It presents with a characteristic electrocardiographic pattern (ST elevation in V1-V3) and is linked to SCN5A gene mutations.
  • However, SCN5A mutations explain only 20-25% of cases, indicating other genetic factors.

Purpose of the Study:

  • To explore genetic and hormonal factors contributing to Brugada syndrome.
  • To highlight diagnostic challenges and management strategies for Brugada syndrome.

Main Methods:

  • Review of existing literature on Brugada syndrome genetics and clinical presentation.
  • Discussion of diagnostic criteria, including pharmacological challenges.
  • Analysis of current treatment recommendations.

Related Experiment Videos

Main Results:

  • A novel gene locus on chromosome 3 has been identified, distinct from SCN5A.
  • Testosterone's role in the male preponderance of the phenotype is hypothesized.
  • The electrocardiographic pattern can be intermittent and may require drug challenge for diagnosis.

Conclusions:

  • Brugada syndrome has a complex genetic basis beyond SCN5A.
  • Diagnosis requires careful exclusion of mimics and consideration of intermittent ECG patterns.
  • Implantation of a cardioverter defibrillator is the recommended treatment for symptomatic patients.